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and proteinuria stabilized at 2.5 g/24 h with pre-
served kidney function.
Castleman disease1 (angiofollicular lymph node 
hyperplasia) is a lymphoproliferative disorder 
which comprises anatomically unicentric or mul-
ticentric forms, with histological variants includ-
ing hyaline-vascular, plasma-cell, or mixed type. 
In some cases, Castleman disease may be associ-
ated with human immunodeficiency virus (HIV) 
and HHV-8.
Castleman disease is rare. No data are avail-
able regarding its incidence in the population, 
while an estimated 10-year prevalence of its mul-
ticentric form in the United States is 2.4 per 
million population.2 The median age at presen-
tation is approximately 35 years for the unicen-
tric type and between 50 and 65 years for the 
multicentric type.
Unicentric form is a localized disease charac-
terized by enlarged, pathological lymph nodes 
within a single area. In contrast to its multicentric 
form, unicentric Castleman disease is potential-
ly completely curable by surgery, leading to par-
tial or complete disease remission, with regres-
sion of tissue amyloid deposits, normalization of 
serum CRP levels, and functional improvement 
of the affected organs.3,4
Acquired amyloidosis is a rare complication of 
Castleman disease, and is usually of the AA type, 
resulting from persistent acute phase response. 
Kidney amyloidosis with nephrotic syndrome as a 
result of unicentric Castleman disease is extreme-
ly rare.4 The reported cases of Castleman disease 
complicated by AA amyloidosis include the plas-
ma-cell type and, less frequently, mixed type.4
As demonstrated in the current case, gluco-
corticoids followed by tumor resection lead to a 
prompt decrease of serum CRP levels and a sta-
ble decrease of proteinuria. Most probably, the 
In May 2014, a 26-year-old Caucasian woman pre-
sented to our outpatient clinic with edema of the 
lower extremities, nephrotic-range proteinuria 
(15.0 g/24 h), and preserved kidney function. Her 
history revealed elevated levels of C-reactive pro-
tein (CRP) since 2009 and mild normocytic ane-
mia. The patient was admitted to the hospital. 
On examination, she was afebrile, with pale skin 
and pitting edema of both shanks. Otherwise, the 
physical examination was unremarkable. Labora-
tory tests showed changes typical for chronic in-
flammation with normocytic anemia (hemoglo-
bin, 8.6 g/dl with a mean corpuscular volume of 
82.7 fl; hyperfibrinogenemia, 12.8 g/l; and elevat-
ed serum CRP levels, 44.2 mg/l) and polyclonal 
gammopathy. No laboratory signs of autoimmune 
reactivity were detected.
Abdominal computed tomography scans 
showed a periaortic mass of 38 × 33 × 45 mm in 
size (FIGURE 1A).
Due to marked proteinuria, a kidney biopsy was 
performed. The principal pathological feature was 
an early stage of renal AA amyloidosis (FIGURE 1BC).
To reduce an inflammatory reaction, a high- 
-dose glucocorticoid therapy was instituted (3 dai-
ly doses of methylprednisolone, 1000 mg IV fol-
lowed by 32 mg/d orally). Serum CRP levels nor-
malized within 2 weeks, and in July 2014, the 
patient underwent surgery with the total exci-
sion of the abdominal mass located in the small 
bowel mesentery. A histopathological examina-
tion revealed a mass consistent with unicentric 
Castleman disease of the human herpesvirus 8 
(HHV-8)-negative, mixed hyaline-vascular and 
plasma-cell type (FIGURE 1D).
Glucocorticoids were tapered and eventually 
discontinued. During 15 months of follow-up, 
CRP levels remained within the normal range 
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reduction of chronic inflammation inhibits the 
amyloid production. Furthermore, as shown pre-
viously,4 amyloid deposits can regress once the 
supply of amyloid precursors is reduced.
Laboratory signs of chronic inflammation pres-
ent for several years without an apparent cause, 
even without clinical symptoms, should raise sus-
picion of Castleman disease. Unfortunately, its 
diagnosis is usually significantly delayed, which 
may lead to irreversible organ damage as a result 
of secondary AA amyloidosis.
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FIGURE 1 A – abdominal computed tomography scan; there is a tumor on the left side of abdominal aorta, superior to the aortic bifurcation (arrow); 
B – Kongo red positivity of focal deposits in renal glomeruli; C – immunopositivity of amyloid deposits in the kidney stained for AA amyloid; D – the 
tumorous lymph node of the mesentery; on the left side, lymph follicle with a small, “burnt out” germinal center and widened distinct mantle zone; on 
the right, sheets of plasma cells
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